Kiniksa Pharmaceuticals International, plc (KNSA) › Net IncomeKiniksa Pharmaceuticals International, plc (KNSA) — Net IncomeAnnual figures by period end, from SEC filings.2017-12-31: -$64.87M2018-12-31: -$103.23M2019-12-31: -$161.87M2020-12-31: -$161.38M2021-12-31: -$157.92M2022-12-31: $183.36M2023-12-31: $14.08M2024-12-31: -$43.19M2025-12-31: $59.01M$59.01M2017-12-31Net Income (USD)2025-12-31Period endedNet IncomeChange YoYSource filing2025-12-31$59.01M—2026-02-24From 2025-01-012024-12-31-$43.19M-406.7%2026-02-24From 2024-01-012023-12-31$14.08M-92.3%2026-02-24From 2023-01-012022-12-31$183.36M—2025-02-25From 2022-01-012021-12-31-$157.92M—2024-02-28From 2021-01-012020-12-31-$161.38M—2023-03-02From 2020-01-012019-12-31-$161.87M—2022-02-24From 2019-01-012018-12-31-$103.23M—2021-02-25From 2018-01-012017-12-31-$64.87M—2019-03-12From 2017-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)